Markets › Stocks › EIKO
EI

Eiko Lifesciences Ltd

NSE: EIKOBSE: 540204Chemicals
Download Research Report7-page PDF
₹53.00
▲ +5.70%
NSE · auto-updates while market open
Mkt Cap
₹81 Cr
P / E
15.2
P / B
1.2
ROE
8.5%
52W High
₹65.90
52W Low
₹45.90
Key Metrics
Market Cap
₹81 Cr
P / E
15.23
P / B
1.18
EV / EBITDA
8.49
ROCE
11.1%
ROE
8.5%
Debt / Equity
0.07
Book Value
₹47.94
EPS
₹3.26
Div Yield
0.0%
Face Value
-
Promoter Holding
39.9%
Revenue · ₹ Cr
10
FY20
12
FY21
25
FY22
18
FY23
28
FY24
38
FY25
53
FY26
Net Profit · ₹ Cr
1
1
1
1
2
5
-4
FY20FY21FY22FY23FY24FY25FY26
EPS · ₹ per share
₹1.6
₹0.9
₹0.9
₹0.7
₹1.6
₹3.3
₹-5.0
FY20FY21FY22FY23FY24FY25FY26
Q1 2026 snapshot
Sales
₹18 Cr
Operating profit
-
OPM
-
Net profit
₹1 Cr
EPS
₹0.93
Scorecard · 7 axes
Quality
Good
75/100
Valuation
Good
15.2×
Growth
Strong
+42.9%
Profitability
Weak
9.8%
Performance
Weak
+0.3%
Entry Point
Avg
80%
Red Flags
Strong
0 flags
Shareholding Pattern
39.9%Promoter
Promoter39.9%
Public60.1%
Quarterly Results · ₹ Cr
QuarterFY18 09QFY18 12Q
Revenue4,23,2818,31,300
Net Profit1,89,90180,900
NPM %44.9%9.7%
AlertPre-trade